Learn About Hemoglobin C Disease

What is the definition of Hemoglobin C Disease?

Hemoglobin C disease is a blood disorder passed down through families. It leads to a type of anemia, which occurs when red blood cells break down earlier than normal.

What are the alternative names for Hemoglobin C Disease?

Clinical hemoglobin C

What are the causes of Hemoglobin C Disease?

Hemoglobin C is an abnormal type of hemoglobin, the protein in red blood cells that carries oxygen. It is a type of hemoglobinopathy. The disease is caused by a problem with a gene called beta globin.

The disease most often occurs in African Americans. You are more likely to have hemoglobin C disease if someone in your family has had it.

What are the symptoms of Hemoglobin C Disease?

Most people do not have symptoms. In some cases, jaundice may occur. Some people may develop gallstones that need to be treated.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hemoglobin C Disease?

In most cases, no treatment is needed. Folic acid supplements may help your body produce normal red blood cells and improve the symptoms of the anemia.

Who are the top Hemoglobin C Disease Local Doctors?
Nirmish R. Shah
Advanced in Hemoglobin C Disease
Hematology | Pediatrics
Advanced in Hemoglobin C Disease
Hematology | Pediatrics

Duke Adult Comprehensive Sickle Cell Center - Clinic 2N

40 Duke Medicine Cir, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Nirmish Shah is a Hematologist and a Pediatrics provider in Durham, North Carolina. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Hemoglobin C Disease. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Shah is currently accepting new patients.

Elite in Hemoglobin C Disease
Elite in Hemoglobin C Disease
BP 1805, Point G, 
Bamako, BKO, ML 

Ogobara Doumbo practices in Bamako, Mali. Doumbo is rated as an Elite expert by MediFind in the treatment of Hemoglobin C Disease. Their top areas of expertise are Malaria, Hemoglobin C Disease, Primary Amebic Meningoencephalitis, and Sepsis.

 
 
 
 
Learn about our expert tiers
Learn More
Cherie B. Hawkins
Experienced in Hemoglobin C Disease
Family Medicine
Experienced in Hemoglobin C Disease
Family Medicine

Advocate Medical Group Primary Care

2535 S Martin Luther King Dr, 
Chicago, IL 
Languages Spoken:
English

Cherie Hawkins is a primary care provider, practicing in Family Medicine in Chicago, Illinois. Dr. Hawkins is rated as an Experienced provider by MediFind in the treatment of Hemoglobin C Disease. Her top areas of expertise are Diabetic Hyperglycemic Hyperosmolar Syndrome, Kearns-Sayre Syndrome, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism.

What is the outlook (prognosis) for Hemoglobin C Disease?

People with hemoglobin C disease can expect to lead a normal life.

What are the possible complications of Hemoglobin C Disease?

Complications may include:

  • Anemia
  • Gallbladder disease
  • Enlargement of the spleen
When should I contact a medical professional for Hemoglobin C Disease?

Contact your health care provider if you have symptoms of hemoglobin C disease.

How do I prevent Hemoglobin C Disease?

You may want to seek genetic counseling if you are at high risk for the condition and are considering having a baby.

What are the latest Hemoglobin C Disease Clinical Trials?
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

Summary: The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: March 31, 2024
Published By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Howard J. Sickle cell disease and other hemoglobinopathies. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 149.

Smith-Whitley K, Kwiatkowski JL. Hemoglobinopathies. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 511.

So JCC, Ma ESK. Hemoglobin and hemoglobinopathies. In: Rifai N, Chiu RWK, Young I, Burnham CAD, Wittwer CT, eds. Tietz Textbook of Laboratory Medicine. 7th ed. St Louis, MO: Elsevier; 2023:chap 77.

Wilson CS, Vergara-Lluri ME, Brynes RK. Evaluation of anemia, leukopenia, and thrombocytopenia. In: Jaffe ES, Arber DA, Campo E, Harris NL, Quintanilla-Martinez L, eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:chap 11.